Sistema Regional de Información
en línea para Revistas Científicas de América Latina,
el Caribe, España y Portugal

EVENTO REUMA-CIMEQ 2022PROGRAMA CIENTÍFICOREUMA-CIMEQ 2022 EVENTSCIENTIFIC PROGRAMDel 7 al 9 de diciembre del 2022Centro Latino-americano de eventos científicos CIMEQLa Habana, CubaPRESIDENTE DE HONORDr. Roberto Castellano GutiérrezPRESIDENTE DEL EVENTODr. C Gil Alberto Reyes Llerena.VICE – PRESIDENTEDr. C. Alfredo Hernández Martínez.

Background: Systemic lupus erythematosus is an autoimmune disease with a complex aetiology. Clinical criteria for SLEDAI activity rely on laboratory determinations for its interpretation.Objective: to identify variations in laboratory parameters predictive of flares in patients with systemic lupus erythematosus.Methods: a retrospective cohort study was performed between the years 2015 to 2020. Thirty-six records of 22 patients of a hospital centre who met the inclusion criteria, were selected. The variables were arranged in groups, epidemiological and clinical variables, personal pathological history and laboratory test results. Statistical analysis was performed using SPSS statistical processing software.Results: female sex predominated (90%) along with mixed skin colour (59.1%). Body mass index offered significant differences between active and non-active lupus (p=0.003). Lower weight (p=0.008), decreased levels of plasma albumin (p=0.002), hemoglobin (p=0.000) and hematocrit (p=0.002) were related to periods of activity. Other parameters with a constant increase and predictive value were globulin levels (p=0.053) and erythrocyte sedimentation rate (p=0.000). The albumin/globulin ratio offered a sharp difference between exacerbations and remissions (p=0.002).Conclusions: the inverted albumin globulin index, low haemoglobin levels, weight reduction and high erythrocyte sedimentation rate have a high predictive value in exacerbations of systemic lupus erythematosus.

Introducción: Las enfermedades pulmonares intersticiales difusas constituyen un grupo amplio de afecciones, con manifestaciones clínicas, expresión radiológica y alteraciones funcionales del intersticio pulmonar. Objetivo: Describir el comportamiento clínico y radiológico de la enfermedad intersticial difusa sintomática en pacientes diagnosticados con colagenosis.Métodos: Se realizó un estudio observacional, descriptivo transversal, con una población compuesta por 33 pacientes con manifestaciones respiratorias secundarias a colagenosis. La muestra estuvo conformada por la totalidad de los pacientes. El análisis estadístico se llevó a cabo por medio de estadística descriptiva de cada variable. Resultados: Existió un mayor número de mujeres afectadas (75.8 %) por esclerosis sistémica (31 %), artritis reumatoide (27 %) y lupus eritematoso sistémico (21 %). La afectación respiratoria predominante fue de 81.8 % con compromiso intersticial asociada a un patrón radiológico de neumonitis intersticial usual con 5 casos (21.4 %), todos ligados a artritis reumatoide. Prevaleció el patrón espirométrico restrictivo en 18 pacientes (24.5 %). Para 25 casos (75.8 %) hubo un retraso diagnóstico menor de 1 año; la colagenosis antecedió a la manifestación respiratoria en 21 casos (63.6 %).Conclusiones: El compromiso intersticial fue la manifestación respiratoria más frecuente; los patrones de neumonitis intersticial usual y la neumonía intersticial no específica predominaron como hallazgos imagenológicos. La secuencia diagnóstica apuntó hacia la colagenosis como el debut del proceso.

Introduction: Systemic sclerosis is a chronic connective tissue disease characterized by vascular dysfunction and microvascular alterations that lead to ischemia and fibrosis of tissues and organs, including the cardiovascular system.Objective: To characterize the cardiac manifestations from the clinical, electro and telecardiographic point of view in patients with systemic sclerosis.Methods: A descriptive, cross-sectional study was carried out in patients from the Reference Center for Rheumatic Diseases, from January 2018 to march 2020. Sociodemographic, clinical, electrocardiographic and radiological variables were analyzed. Chi-square and Fisher's exact tests were used to identify association; Linear trend was used in the variable time of diagnosis.Results: The diffuse form was present in 69,6 %; there were 28,2 % of patients between 50 and 59 years of age. The female sex was 92,95 %, those with non-white skin 57,6 % and with more than 10 years of diagnosis there was 36,6 %. Dyspnea on exertion was the most frequent symptom with 68,2 %. Heart murmur was evidenced in 18,8 %. Ventricular hypertrophy was observed in 31,8 % of cases.Conclusions: The frequency of cardiovascular pain was significant; exertional dyspnea was the most frequent symptom described by the patients and heart murmur, the most identified finding in the physical examination.

Las enfermedades reumáticas son un grupo de afecciones, la mayoría de ellas con afectación inmunológica y compromiso sistémico, que generan distintos grados de discapacidad funcional y disminución de la percepción de calidad de vida de los pacientes que las padecen. Constituyen una de las primeras causas de discapacidad, de invalidez temporal y definitiva, de afectación laboral y se sitúan dentro de los 10 primeras motivos de consultas en el primer nivel de atención de salud. Los pacientes con este tipo de enfermedad han sido considerados como pacientes inmunodeprimidos lo cual no se corresponde directamente con los mecanismos de producción de la gran mayoría de las enfermedades reumáticas. En el presente reporta se abordan los mitos y realidades que engloban a las enfermedades reumáticas y la supuesta inmunosupresión que generan, desde la perspectiva etiopatogénica de este grupo de enfermedades. El esclarecimiento de estos elementos es indispensable para poder enfrentar adecuadamente, desde el punto de vista terapéutico y de autocuidado a los pacientes con enfermedades reumáticas. Se concluye, que en base a los elementos etiopatogénicos de las enfermedades reumáticas y el análisis de la expresión de la respuesta inmunológica normal y en pacientes reumáticos, estos no pueden ser considerados como personas inmunodeprimidas. La prescripción de inmunosupresores se realiza con la finalidad de restaurar la respuesta inmunológica normal.

Introduction: The control of rheumatic diseases constitutes a challenge for health professionals. There are multiple factors that can influence its control, nutritional status and systematic physical activity are some of them.Objective: To evaluate the behavior of the nutritional status and the practice of physical activities in patients with rheumatic diseases during the COVID-19 pandemic.Methods: Basic, non-experimental, descriptive and cross-sectional research that included as a study population a cohort of 63 patients diagnosed with rheumatic diseases according to the criteria of the American College of Rheumatology. The general characteristics of the patients, the rheumatic diseases included in the research, the main digestive manifestations identified, and the Sperman correlation test was used to identify the possible relationship between the study variables.Results: Mean age of 53.36 years, with a predominance of female patients (82.54%), with rheumatoid arthritis (53.97%) and pharmacological adherents (96.82%). After the confinement was over, there was an increase in overweight (41.27%) and obese (9.52%) patients. A decrease in the frequency of physical activities was found with a predominance of patients who perform physical activities less than 3 times a week; 14.28% report that they never exercise.Conclusions: It was identified that during the period of confinement by COVID-19 there were negative variations in the nutritional status and frequency of physical activities of patients with RD that could be related to the clinical activity of this type of disease. 

Introduction: Disability is considered a health problem worldwide. People with physical disabilities are susceptible to different health problems. Despite being a prioritized group, access to health services is lower than that of the general population, conditioned by the presence of different types of barriers.Objective: To describe the barriers and facilitators of access to primary health care in people with physical disabilities.Methods: A bibliographic review was carried out whose methodology was based on the search, selection, review, interpretation and synthesis of the scientific evidence related to the research problem. It was used as a source of primary scientific literature published in the databases Scielo, Redalyc, Latindex and PudMed in the last 5 years, with the MeSH search terms in Spanish, English and Portuguese.Results: A total of 67 documents were identified, of which 46 were used in the research carried out. The remaining 21 manuscripts were excluded due to methodological deficiencies that limited their use.Conclusions: The access of people with physical disabilities to health services is conditioned by situations that are interpreted as barriers or facilitators. In this sense, the factors related to the national health system and the characteristics and environment of the person with a disability can act as a barrier or as a facilitator, depending on their expression.

El lupus eritematoso sistémico es una enfermedad inflamatoria sistémica cuyo proceso inflamatorio genera un importante número de manifestaciones clínicas articulares y extraarticulares. Dentro de las manifestaciones extraarticulares destaca, entre otras, la afectación neurológica, el compromiso puede ser tanto a nivel del sistema nervioso central o periférico. El objetivo de la presente investigación es presentar el caso de una paciente de 56 años de edad, con diagnóstico de lupus eritematoso sistémico de 18 años de evolución y que ha presentado cuadro crónico de cefalea, neuropatía periférica y cuadro de miastenia gravis como manifestaciones neurológicas de la enfermedad. Se considera importante el reporte de este caso para dar a conocer la importancia que revisten las manifestaciones neurológicas como parte de las manifestaciones extraarticulares de esta enfermedad; siendo este tipo de afección determinantes en el curso de la enfermedad y en la calidad de vida de los pacientes.

Fue el lunes 12 de diciembre de 2011. Visite LABCEL sugerido por la Dra. Mairim Lago Queija, decana de la Facultad de Ciencias Médicas Miguel Enríquez en aquel momento, para evaluar si me interesaba laborar en el Laboratorio Central de Líquido Cefalorraquídeo (LABCEL), debido a que necesitaba incorporar un médico a dicho centro.

In the present work an analysis of the doctrine contained in the judgment of the Supreme Court no. 27/2022, of January 12. After studying the regulation of the new art. 15 of the ET, it is intended to find an answer to the following question: does the employment relationship of an interim worker who provides his services a few days after the completion of the substitution become indefinite?